Barnes-Jewish Hospital
St Louis, Missouri, 63110, United States
NCT Number: NCT00962546
Cerebral vasospasm is a devastating complication of subarachnoid hemorrhage after cerebral aneurysm rupture leading to cerebral ischemia and potentially cerebral infarction. The current gold standard diagnostic imaging study for cerebral vasospasm is catheter cerebral angiography, an invasive diagnostic procedure carrying a complication rate of 1-2% per procedure. Computed tomographic perfusion imaging (CTP) and computed tomographic angiography (CTA) are noninvasive diagnostic imaging studies frequently utilized in the evaluation of embolic and thrombotic cerebral infarct. The investigators hypothesize that CTP and CTA may be utilized as screening tools for cerebral vasospasm following aneurysmal subarachnoid hemorrhage requiring treatment and provide prognostic information.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at time of catheter angiogram
Time frame: At time of hospital discharge
Time frame: at time of catheter angiogram
Washington University School of Medicine
Other
Computed Tomographic Perfusion and Computed Tomographic Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01158508
Aneurysm, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT02389634
Brain Diseases, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03517670
Brain Diseases, Cardiovascular Diseases
Nantes, France
View Trial DetailsNCT03214705
Brain Diseases, Cardiovascular Diseases
Asyut, Egypt
View Trial Details